UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 33

Sortiert nach

Letter: the value of quality liver biopsy before initiation of corticosteroids for severe alcoholic hepatitis

Alimentary pharmacology & therapeutics, 2022-04, Vol.55 (7), p.889-890

2022

Link zum Volltext

Verfügbarkeit prüfen

Impairment of aryl hydrocarbon receptor signalling promotes hepatic disorders in cancer cachexia

Journal of cachexia, sarcopenia and muscle, 2023-06, Vol.14 (3), p.1569-1582

2023

Link zum Volltext

Verfügbarkeit prüfen

Clinical Presentation and Gene Expression of Acute Alcohol‐Induced Microvesicular Steatosis Mimicking Alcoholic Hepatitis

Hepatology communications, 2021-04, Vol.5 (4), p.618-628

2021

Link zum Volltext

Verfügbarkeit prüfen

Deficient IL‐6/Stat3 Signaling, High TLR7, and Type I Interferons in Early Human Alcoholic Liver Disease: A Triad for Liver Damage and Fibrosis

Hepatology communications, 2019-07, Vol.3 (7), p.867-882

2019

Link zum Volltext

Verfügbarkeit prüfen

Jaundice with severe leucocytosis

Journal of hepatology, 2024-03, Vol.80 (3), p.e103-e105

2024

Link zum Volltext

Verfügbarkeit prüfen

Screening for NAFLD and its severity in type 2 diabetic patients: Value of magnetic resonance imaging and outstanding issues

Journal of hepatology, 2023-05, Vol.78 (5), p.e166-e167

2023

Link zum Volltext

Verfügbarkeit prüfen

Frailty in metabolic dysfunction-associated fatty liver disease is related to the presence of diabetes and the severity of liver fibrosis

Journal of hepatology, 2023-06, Vol.78, p.S639-S640

2023

Link zum Volltext

Verfügbarkeit prüfen

THU-473 - Frailty in metabolic dysfunction-associated fatty liver disease is related to the presence of diabetes and the severity of liver fibrosis

Journal of hepatology, 2023-06, Vol.78, p.S639-S640

2023

Link zum Volltext

Verfügbarkeit prüfen

Treatment of severe alcoholic hepatitis: past, present and future

European journal of clinical investigation, 2017-07, Vol.47 (7), p.531-539

2017

Link zum Volltext

Verfügbarkeit prüfen

Discovery of the gut microbial signature driving the efficacy of prebiotic intervention in obese patients

Gut, 2020-11, Vol.69 (11), p.1975

2020

Link zum Volltext

Verfügbarkeit prüfen

Unlocking liver health: Can tackling myosteatosis spark remission in metabolic dysfunction-associated steatotic liver disease?

Liver international, 2024-04

2024

Link zum Volltext

Verfügbarkeit prüfen

Patients with chronic liver diseases are at risk for diabetes even before development of cirrhosis

Journal of hepatology, 2022-07, Vol.77, p.S736-S737

2022

Link zum Volltext

Verfügbarkeit prüfen

Duodenal CD8+ T resident memory cell apoptosis contributes to gut barrier dysfunction and microbial translocation in early alcohol‐associated liver disease in humans

Alimentary pharmacology & therapeutics, 2022-09, Vol.56 (6), p.1055-1070

2022

Link zum Volltext

Verfügbarkeit prüfen

SAT-071-Insulin resistance in cirrhotic patients: results from a large prospective study

Journal of hepatology, 2019-04, Vol.70 (1), p.e658-e659

2019

Link zum Volltext

Verfügbarkeit prüfen

A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis

The New England journal of medicine, 2024-02, Vol.390 (6), p.497-509

2024

Link zum Volltext

Verfügbarkeit prüfen

THU041 - Muscle fat infiltration in obese patients is associated with NAFLD related fibrosis severity - results from a prospective imaging study

Journal of hepatology, 2020-08, Vol.73, p.S161-S162

2020

Link zum Volltext

Verfügbarkeit prüfen

Muscle fat infiltration in obese patients is associated with NAFLD related fibrosis severity - results from a prospective imaging study

Journal of hepatology, 2020-08, Vol.73, p.S161-S162

2020

Link zum Volltext

Verfügbarkeit prüfen

THU-493 - The evolution of the muscle compartment from the listing to six-month post-transplantation: a longitudinal monocentric study

Journal of hepatology, 2023-06, Vol.78, p.S464-S465

2023

Link zum Volltext

Verfügbarkeit prüfen

The evolution of the muscle compartment from the listing to six-month post-transplantation: a longitudinal monocentric study

Journal of hepatology, 2023-06, Vol.78, p.S464-S465

2023

Link zum Volltext

Verfügbarkeit prüfen

Hepatic cell proliferation plays a pivotal role in the prognosis of alcoholic hepatitis

Journal of hepatology, 2015-09, Vol.63 (3), p.609-621

2015

Link zum Volltext

Verfügbarkeit prüfen

Hepatoprotective Effects of Indole, a Gut Microbial Metabolite, in Leptin-Deficient Obese Mice

The Journal of nutrition, 2021-06, Vol.151 (6), p.1507-1516

2021

Link zum Volltext

Verfügbarkeit prüfen

FRI-316-Liver fetuin-A in activated macrophages is a key feature of nonalcoholic steatohepatitis in mice and humans

Journal of hepatology, 2019-04, Vol.70 (1), p.e535-e535

2019

Link zum Volltext

Verfügbarkeit prüfen

New imaging assisted methods for liver fibrosis quantification: Is it really favorable to classical transient elastography?

Journal of hepatology, 2015-09, Vol.63 (3), p.765-766

2015

Link zum Volltext

Verfügbarkeit prüfen

Kupffer cell depletion prevents but has no therapeutic effect on metabolic and inflammatory changes induced by a high‐fat diet

The FASEB journal, 2011-12, Vol.25 (12), p.4301-4311

2011

Link zum Volltext

Verfügbarkeit prüfen

Liver and systemic insulin resistance

Hepatology (Baltimore, Md.), 2014-09, Vol.60 (3), p.1113-1114

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 33

Suche als RSS-Feed

Aktive Filter

SpracheJapanisch

KollektionWK Lippincott Williams & Wilkins–Connect here FIRST to enable access

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(33)

Sprache

Englisch
(33)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Letter: the value of quality liver biopsy before initiation of corticosteroids for severe alcoholic hepatitis

Impairment of aryl hydrocarbon receptor signalling promotes hepatic disorders in cancer cachexia

Clinical Presentation and Gene Expression of Acute Alcohol‐Induced Microvesicular Steatosis Mimicking Alcoholic Hepatitis

Deficient IL‐6/Stat3 Signaling, High TLR7, and Type I Interferons in Early Human Alcoholic Liver Disease: A Triad for Liver Damage and Fibrosis

Jaundice with severe leucocytosis

Screening for NAFLD and its severity in type 2 diabetic patients: Value of magnetic resonance imaging and outstanding issues

Frailty in metabolic dysfunction-associated fatty liver disease is related to the presence of diabetes and the severity of liver fibrosis

THU-473 - Frailty in metabolic dysfunction-associated fatty liver disease is related to the presence of diabetes and the severity of liver fibrosis

Treatment of severe alcoholic hepatitis: past, present and future

Discovery of the gut microbial signature driving the efficacy of prebiotic intervention in obese patients

Unlocking liver health: Can tackling myosteatosis spark remission in metabolic dysfunction-associated steatotic liver disease?

Patients with chronic liver diseases are at risk for diabetes even before development of cirrhosis

Duodenal CD8+ T resident memory cell apoptosis contributes to gut barrier dysfunction and microbial translocation in early alcohol‐associated liver disease in humans

SAT-071-Insulin resistance in cirrhotic patients: results from a large prospective study

A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis

THU041 - Muscle fat infiltration in obese patients is associated with NAFLD related fibrosis severity - results from a prospective imaging study

Muscle fat infiltration in obese patients is associated with NAFLD related fibrosis severity - results from a prospective imaging study

THU-493 - The evolution of the muscle compartment from the listing to six-month post-transplantation: a longitudinal monocentric study

The evolution of the muscle compartment from the listing to six-month post-transplantation: a longitudinal monocentric study

Hepatic cell proliferation plays a pivotal role in the prognosis of alcoholic hepatitis

Hepatoprotective Effects of Indole, a Gut Microbial Metabolite, in Leptin-Deficient Obese Mice

FRI-316-Liver fetuin-A in activated macrophages is a key feature of nonalcoholic steatohepatitis in mice and humans

New imaging assisted methods for liver fibrosis quantification: Is it really favorable to classical transient elastography?

Kupffer cell depletion prevents but has no therapeutic effect on metabolic and inflammatory changes induced by a high‐fat diet

Liver and systemic insulin resistance

Aktive Filter

Suchergebnisse filtern